Applications of Z-3-Chloro-1-(2-Chlorophenyl)-2-(4-Fluorophenyl)-Oxirane in Industrial Manufacturing

Z-3-Chloro-1-(2-Chlorophenyl)-2-(4-Fluorophenyl)-Oxirane serves as an advanced intermediate in several tightly regulated chemical synthesis chains, predominantly in the pharmaceutical and agrochemical sectors. As an ISO-certified manufacturer, we supply this compound to established industry leaders seeking stable supply, documented traceability, and reliable formulation repeatability. Below, we outline specific, real-world application scenarios substantiated by downstream quality and compliance requirements.

1. Synthesis of Targeted Active Pharmaceutical Ingredients (APIs)

API manufacturers use this oxirane derivative as a chiral epoxide building block in the enantioselective synthesis of complex pharmaceutical actives. Its functionalized aromatic and halogen substituents allow direct input into multi-step reaction sequences involving epoxide ring opening and subsequent coupling, where batch records require meticulous documentation to pass regulatory inspections.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) general chapters relevant to intermediates
• European Pharmacopoeia monographs for process precursors
• EDQM Certificates of Suitability (CEP) process traceability

Typical usage ratio

• 0.5%–3% w/w in specialized synthetic steps, adjusted according to final API yield targets and route specificity

Downstream process integration

• Introduced during the enantioselective epoxidation step or as a reactive substrate for nucleophilic attack, after solvent conditioning and prior to main intermediate purification

Final product types

• Chiral nonsteroidal anti-inflammatory drug (NSAID) actives
• Antihypertensive agent intermediates
• Targeted oncology drug candidates

2. Plant Protection Chemical Synthesis (Agrochemical Intermediate)

Major crop science manufacturers employ this compound as a customizable epoxide ring donor in the multi-stage synthesis of fungicides and insecticides. The halogenated phenyl structure ensures tight control over downstream reactivity, giving agrochemical processors greater predictability in field performance and environmental degradation profiles.

Industry compliance standards

• FAO/WHO Specifications for Agrochemical Technicals
• REACH Regulation (EC) No 1907/2006 for precursor handling
• ISO 9001:2015 Quality Management for chemical production
• Chinese National Standard GB 4839-2004 (Pesticide Technicals)

Typical usage ratio

• Typically 1.2%–5% w/w of total active mass; adjusted according to synthesis yield optimization and environmental safety thresholds

Downstream process integration

• Added in the controlled epoxidation or ring transformation step following initial condensation, and directly prior to the insertion of side-chain modifiers

Final product types

• Triazole-based fungicide actives
• Pyridine-derived insecticide intermediates
• Post-emergence herbicide scaffolds

3. Fine Chemical Intermediates for Specialty Polymers

Producers of high-precision specialty polymers utilize this compound as a reactive monomer modifier in the construction of custom aromatic epoxy systems. Its distinct halogenated and fluorinated ring structures enable downstream users to finely adjust polymer backbone rigidity and chemical resistance for electrical and coatings industries.

Industry compliance standards

• EN ISO 9001:2015 and ISO 14001:2015 for specialty polymer production
• US EPA TSCA Inventory Regulations for monomers
• RoHS Directive (2011/65/EU) for electronics applications
• UL 94 flammability requirements for polymeric materials

Typical usage ratio

• 0.25%–2% of total polymer formulation mass; adjustments based on polymer chain targeting and end-use electrical properties

Downstream process integration

• Introduced post-prepolymerization as a chain extender or crosslinking agent under inert reaction conditions, prior to final curing

Final product types

• High-performance epoxy resins for electronics encapsulation
• Solvent-resistant coating bases
• Precision optical polymer parts

4. Development of Analytical Reference Standards

Certified reference material (CRM) laboratories and analytical reagent specialists incorporate this compound into controlled synthesis routes, producing calibration markers needed for chromatography and spectrometry quality control. The fluorinated and chlorinated motifs provide distinct retention times and spectra, supporting the calibration traceability required in regulated environments.

Industry compliance standards

• ISO 17034: General requirements for reference material producers
• ISO/IEC 17025 accreditation for calibration laboratories
• USP General Chapter <1112> Analytical Instrument Qualification
• OECD Guidelines for Good Laboratory Practice (GLP)

Typical usage ratio

• 0.01%–0.1% of total calibration solution mass, determined by target analytical concentration and detection limits

Downstream process integration

• Reacted under controlled conditions to generate primary standards, which are then used as spiking agents or reference points in HPLC and GC assay calibration

Final product types

• Certified reference mixtures for pharmaceutical quality control labs
• Analytical comparison standards for screening pesticide residues
• Custom CRM kits for regulated testing environments

5. Intermediate for Synthesis of Medicinal Chemistry Screening Libraries

Medicinal chemistry groups at major pharmaceutical companies and contract research organizations use this compound as a pivotal scaffold in combinatorial library construction. Its halogenated epoxide core allows rapid diversification via nucleophilic substitution, facilitating high-throughput synthesis of lead candidate molecules in early-stage drug discovery.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• FDA Guidance for Industry: CGMP for Phase 1 Investigational Drugs
• EMA: Guidelines for Chemistry, Manufacturing and Controls Documentation
• ISO 9001:2015 for research chemical supply

Typical usage ratio

• Variable (0.2%–2%) depending on library layout, reaction stoichiometry, and specific screening design

Downstream process integration

• Introduced at the primary diversification step or during parallel synthesis cycles, followed by rapid purification and characterization

Final product types

• Medicinal chemistry screening libraries containing halogenated epoxide motifs
• Lead compound pools for preclinical pharmacology assessment
• Reference samples for SAR studies